Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma

por Zarogoulidis, Paul, Huang, Haidong, Tsiouda, Theodora, Sardeli, Chrysa, Trakada, Georgia, Veletza, Lemonia, Kallianos, Anastasios, Kosmidis, Christoforos, Rapti, Aggeliki, Papaemmanouil, Liana, Hatzibougias, Dimitrios, Drougas, Dimitrios, Bai, Chong, Hohenforst-Schmidt, Wolfgang
Publicado 2017

Immunotherapy “Shock” a case series of PD-L1 100% and pembrolizumab first-line treatment

por Zarogoulidis, Paul, Athanasiou, Evaggelia, Tsiouda, Theodora, Hatzibougias, Dimitrios, Huang, Haidong, Bai, Chong, Trakada, Georgia, Veletza, Lemonia, Kallianos, Anastasios, Kosmidis, Christoforos, Barbetakis, Nikolaos, Paliouras, Dimitrios, Rapti, Aggeliki, Drougas, Dimitrios, Hohenforst-Schmidt, Wolfgang
Publicado 2017

Psoriatic arthritis due to nivolumab administration a case report and review of the literature

por Sapalidis, Konstantinos, Kosmidis, Christoforos, Michalopoulos, Nikolaos, Koulouris, Charilaos, Mantalobas, Stylianos, Giannakidis, Dimitrios, Munteanu, Alexandru, Surlin, Valeriu, Laskou, Stella, Zarogoulidis, Paul, Drougas, Dimitrios, Sardeli, Crysanthi, Karapantzou, Chrysanthi, Karapantzos, Ilias, Hohenforst-Schmidt, Wolfgang, Huang, Haidong, Kesisoglou, Isaak
Publicado 2018